Immunotherapy drugs are commonly used to treat advanced cancers such as melanoma, bladder cancer, and advanced lung cancer, among others. The drugs usually work by stimulating the body’s natural ability to fight off cancerous cells. Immunotherapies are typically used in combination with other treatments such as chemotherapy or radiation.
The primary benefit of immunotherapy is that it is relatively less toxic than other cancer treatments. The drugs do not usually affect healthy cells and organs, which means there may be fewer side effects than chemotherapy or radiotherapy. Furthermore, immunotherapy drugs can have longer-term effects, as they can continue to work after the initial course of treatment.
Immunotherapy may also be more effective than other cancer treatments. For instance, a review published in 2018 found that certain types of immunotherapy drugs had better outcomes than chemotherapy, with some studies showing a survival benefit in patients with advanced cancer. Another review, published in 2019, found that immunotherapies had higher overall response rates in certain types of cancer.
Finally, immunotherapies are relatively inexpensive compared to other cancer treatments. While they are not always covered by insurance, they are usually less expensive than traditional chemotherapy and radiation treatments. This makes immunotherapies more accessible to people who may not be able to afford more expensive treatments.
Overall, immunotherapy drugs can have a number of positive benefits for people with cancer. They are generally less toxic than other treatments, may be more effective in certain situations, and are usually more affordable than other cancer treatments. Furthermore, the drugs can have life-saving effects for those with certain types of cancer. For these reasons, immunotherapies present a promising option for those facing a cancer diagnosis.
Article Created by A.I.